ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 13 filers reported holding ANEBULO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $503,580 | +47.9% | 157,862 | +1.1% | 0.06% | +13.0% |
| Q2 2023 | $340,523 | -26.4% | 156,203 | 0.0% | 0.05% | -48.6% |
| Q1 2023 | $462,360 | +23.3% | 156,203 | 0.0% | 0.10% | +16.7% |
| Q4 2022 | $374,888 | -14.2% | 156,203 | 0.0% | 0.09% | +3.4% |
| Q3 2022 | $437,000 | -53.6% | 156,203 | -13.8% | 0.09% | -49.4% |
| Q2 2022 | $942,000 | -23.1% | 181,199 | 0.0% | 0.17% | +6.8% |
| Q1 2022 | $1,225,000 | +14.4% | 181,199 | +5.2% | 0.16% | +0.6% |
| Q4 2021 | $1,071,000 | -7.7% | 172,309 | 0.0% | 0.16% | +95.1% |
| Q3 2021 | $1,160,000 | -3.7% | 172,309 | -1.4% | 0.08% | -15.5% |
| Q2 2021 | $1,204,000 | – | 174,811 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |